We are live on
!
Find out more
Syndax Pharmaceuticals
SNDX
SNDX
57 hedge funds and large institutions have $79.8M invested in Syndax Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
61.15% more ownership
Funds ownership: 0% → 61.15% (+61%)
36% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 11
27% more funds holding
Funds holding: 45 → 57 (+12)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
55% less capital invested
Capital invested by funds: $176M → $79.8M (-$95.9M)
Holders
57
Holders Change
+12
Holders Change %
+26.67%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
15
Increased
15
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.73M |
| 2 |
Jennison Associates
New York
|
-$3.18M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$2.21M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$915K |
| 5 |
GE
General Electric
Evendale,
Ohio
|
-$726K |
